Skip to main content

CORRECTION: Oct 29, 2001


CORRECTION: In the 10-22-01 issue of BioInform, the p. 8 article, “NetGenics Snags Aventis as its Third DiscoveryCenter Customer,” incorrectly stated that Aventis Pharmaceuticals had licensed the DiscoveryCenter platform. This should have read Avalon Pharmaceuticals.

We apologize for any inconvenience this error may have caused our readers.

Filed under

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.